San Diego-Artes Medical received an approvable letter for ArteFill from the U.S. Food and Drug Administration (FDA) on January 16, 2004.
Comorbidities Women With Hair Loss May Experience
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
The Weekly Roundup: March 20-24
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
Lebrikizumab Demonstrates Promising Results in Atopic Dermatitis
Air Pollution from Wildfire Smoke Can Exacerbate Skin Conditions
2 Clarke Drive Cranbury, NJ 08512